1. Targeting metabolism: A potential strategy for hematological cancer therapy
   Xue Tang et al, 2022, World Journal of Clinical Cases CrossRef
2. The Activation of the Tumor Suppressor Protein p53 by Acriflavine Leads to Mitochondrial Dysfunction and Improves the Radiosensitivity of Colon Cancer Cells
   Caizhao Lin et al, 2022, Journal of Immunology Research CrossRef
3. Acriflavine, an Acridine Derivative for Biomedical Application: Current State of the Art
   Kinga Piorecka et al, 2022, Journal of Medicinal Chemistry CrossRef
4. The effect of Azo-dyes on glioblastoma cells in vitro
   Ani-Simona Sevastre et al, 2023, Saudi Journal of Biological Sciences CrossRef
5. Hypoxia-inducible transcription factors: architects of tumorigenesis and targets for anticancer drug discovery
   Alexander McDermott et al, 2024, Transcription CrossRef
6. Repurposing of Acriflavine to Target Chronic Myeloid Leukemia Treatment
   Rawan Nehme et al, 2021, Current Medicinal Chemistry CrossRef
7. Molecular determinants of response to 5-fluorouracil-based chemotherapy in colorectal cancer: The undisputable role of micro-ribonucleic acids
   Amirsaeed Sabeti Aghabozorgi et al, 2020, World Journal of Gastrointestinal Oncology CrossRef
8. Polyunsaturated fatty acids and DNA methylation in colorectal cancer
   Mostafa Moradi Sarabi et al, 2019, World Journal of Clinical Cases CrossRef
9. Downregulation of topoisomerase 1 and 2 with acriflavine sensitizes bladder cancer cells to cisplatin-based chemotherapy
   Parisa Zargar et al, 2022, Molecular Biology Reports CrossRef
10. Is acriflavine an efficient co-drug in chemotherapy?
    Kinga Piorecka et al, 2023, RSC Advances CrossRef